Latest Organofluorides Stories
DALLAS, March 27, 2015 /PRNewswire/ -- The Fluoropolymers Market is expected to grow at a CAGR of 5.2%, in terms of volume, over the next five years to reach 380.2 KT by
Conference Call Scheduled for Today at 4:30 p.m. ET to Provide Investor Update SAN DIEGO, March 24, 2015 /PRNewswire/ -- Lpath, Inc.
DALLAS, March 24, 2015 /PRNewswire/ -- The report "Fluoropolymer Market by Type (PTFE, PVDF, FEP, and Fluoroelastomers), by Application (Automotive & Transportation,
TOKYO and SAN FRANCISCO, March 24, 2015 /PRNewswire/ -- Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc.
Bernstein Liebhard LLP is representing numerous Risperdal plaintiffs in the Pennsylvania litigation, all of whom allegedly experienced excessive male breast growth due to their use of the antipsychotic
PHILADELPHIA, March 20, 2015 /PRNewswire/ -- A Philadelphia jury today affirmed by a 10-2 vote that Janssen Pharmaceuticals, a division of Johnson & Johnson, failed to warn of the risk to
WASHINGTON, March 18, 2015 /PRNewswire/ -- USPLabs Inc. has been made aware that U.S.
--- Significant Survival Benefit Observed in Pre-Specified Subgroups Including Patients with Brain Metastases and Patients with Baseline Liver Metastases --- SAN FRANCISCO, March
DALLAS, March 17, 2015 /PRNewswire/ -- The report "Fluorosurfactants Market by Type (Amphoteric, Nonioninc, Anionic and Cationic), by Application (Paints & Coatings,
The Firm is looking forward to a status conference on March 19, 2015 that will discuss issues that affect hundreds of Risperdal lawsuit claimants. New York,